Records containing: Hepatocellular Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase Ib Study of PDR001 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
-
CLINICAL_TRIALS study record update · 2020-12-19Feasibility and Clinical Outcome of TIPS Combined With Subsequent Microwave Ablation in HCC Patients With Refractory Ascites
-
CLINICAL_TRIALS study record update · 2020-12-14A Phase I Trial of Sorafenib and LBH589 in the Treatment of Advanced HCC
-
CLINICAL_TRIALS study record update · 2020-12-07Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2020-12-04A Single Center Experience:Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With Early and Intermediate HCC.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-12-04The PIONEER Initiative: Precision Insights On N-of-1 Effectiveness Research. Tissue Ownership by the Individual With the Return of Actionable Information to the Individual Patient and Physician (Precision Oncology)
-
CLINICAL_TRIALS study record update · 2020-12-03MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison
-
CLINICAL_TRIALS study record update · 2020-12-03A Multicentric, Open-Label Study to Evaluate Tislelizumab in Combination With Transarterial Chemoembolization as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2020-12-02A Randomized Phase 2 Study of LY2157299 Versus LY2157299 - Sorafenib Combination Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2020-11-30Comparison of Immunological Response After Microwave Ablation and Irreversible Electroporation of Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2020-11-24Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Small Hepatocellular Carcinoma：A Phase III, Prospective, Randomized, Open, Parallel Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-11-20Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2020-11-16Effects of Telephone Follow- up Consultations on Discharged Liver Cancer Following Non-surgical Treatment
-
CLINICAL_TRIALS study record update · 2020-11-13HAIC Synchronously Combined With Bevacizumab and Toripalimab First-line for Advanced Hepatocellular Carcinama
-
CLINICAL_TRIALS study record update · 2020-11-12Phase II Study of Pembrolizumab (Keytruda®) in Advanced Hepatocellular Carcinoma (HCC)
-
CLINICAL_TRIALS study record update · 2020-11-12A Phase I/II Study of Bavituximab and Sorafenib In Patients With Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2020-11-04A Multicenter, Open-label, Single-arm Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT Using SIR-Spheres for the Treatment of Patients With HepatoCellular Carcinoma That Are Candidates for Locoregional Therapies
-
CLINICAL_TRIALS study record update · 2020-10-30A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment
-
CLINICAL_TRIALS study record update · 2020-10-30A Phase 1 Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN02385 in Participants With Select Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2020-10-29Precision Study on "Cocktail" Therapy to Improve the Efficacy of Hepatitis B-related Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2020-10-26Neoadjuvant Transartery Chemoembolization Plus Artery Infusion Chemotherapy With Surgery Versus Surgery Alone for Hepatocellular Carcinoma Patients With Barcelona Clinic Liver Cancer (BCLC) B Stage: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-10-26Neoadjuvant Transartery Chemoembolization Plus Artery Infusion Chemotherapy With Surgery Versus Surgery Alone for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-10-26Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation: a Multi-center Prospective Case-control Study
-
CLINICAL_TRIALS study record update · 2020-10-22A Phase I/II Multicenter, Open-label Study of DKN-01 to Investigate the Anti-tumor Activity and Safety of DKN-01 in Patients With Hepatocellular Carcinoma and WNT Signaling Alterations
-
CLINICAL_TRIALS study record update · 2020-10-22A Phase II Clinical Study of Transarterial Chemoembolization (TACE) Plus Hepatic Arterial Infusion Chemotherapy (HAIC) With Oxaliplatin and Raltitrexed for Barcelona Stage C Hepatocellular Carcinoma (HCC)